Logo 1.png
Aeterna Zentaris Reports Fourth Quarter and Full Year 2020 Financial Results
March 25, 2021 08:05 ET | Aeterna Zentaris Inc
– Company executing on growth strategy to build-out pipeline of development assets – Pivotal Phase 3 safety and efficacy study AEZS-130-P02 (“Study P02”) expected to commence in Q2 2021 ...
logo-alt.png
Global Diabetes Drugs Market–Analysis and Demand with Forecast Overview to 2029 - by PMI
January 12, 2021 10:05 ET | PMI
Covina, CA, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The significant growth in the market can be attributed to factors, such as the rising prevalence of diabetes and the increasing number of programs...
logo.png
University of Calgary Joins the Phase II Trial of LSALT Peptide for the Treatment of Complications in Hospitalized COVID-19 Patients
January 05, 2021 07:50 ET | Arch Biopartners
TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that the University of Calgary Cumming School of...
PDF to PNG Logo.png
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Emisphere Technologies, Inc. Buyout
November 12, 2020 12:33 ET | Rigrodsky & Long, P.A.
WILMINGTON, Del., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating Emisphere Technologies, Inc. (“Emisphere”) (OTC: EMIS) regarding possible breaches...
BES_Mark.jpg
EMISPHERE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EMIS and Encourages Investors to Contact the Firm
November 09, 2020 13:46 ET | Bragar Eagel & Squire
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of...
nn_logo_cmyk_blue_small.jpg
Novo Nordisk A/S – Share repurchase programme
October 05, 2020 08:35 ET | Novo Nordisk A/S
Bagsværd, Denmark, 5 October 2020 – On 6 August 2020, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council...
Patient Entrepreneur Amin Zayani of Med Angel BV Selected as the Winner of the 2017 Lyfebulb-Novo Nordisk Innovation Award
November 08, 2017 09:14 ET | Lyfebulb
COPENHAGEN, Denmark, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Patient Entrepreneur and Founder & CEO of Med Angel BV, Amin Zayani was named the recipient of the 2017 Lyfebulb-Novo Nordisk Innovation...
Biopharmaceutical Market Scope Rising With Escalating Health Concerns - IndustryARC
March 27, 2017 22:30 ET | IndustryARC
Hyderabad, India, March 27, 2017 (GLOBE NEWSWIRE) -- The report “Biopharmaceutical Market: By Source (Unicellular & Multicellular Systems) By Products (Vaccines, Enzymes, Others) Manufacturing...
Infusion Therapy Devices Market to Rise Ahead Due to Global Increase in Elderly Population – IndustryARC Research
March 11, 2017 11:00 ET | IndustryARC
Hyderabad, India, March 11, 2017 (GLOBE NEWSWIRE) -- The report “Infusion Therapy Devices Market: By Type(Infusion Method, Operation Type, Infusion Type) By Types of Infusion Pumps (Large Volume...
NVO DEADLINE NOTICE: Rosen Law Firm Reminds Novo Nordisk A/S Investors of Important March 13 Deadline in Class Action – NVO
March 02, 2017 18:18 ET | The Rosen Law Firm PA
NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Novo Nordisk A/S securities (NYSE: NVO) from April 30, 2015 through October 27,...